Publication & Citation Trends
Publications
31 total
ABL Mutations in Late Chronic Phase Chronic Myeloid Leukemia Patients With Up-Front Cytogenetic Resistance to Imatinib Are Associated With a Greater Likelihood of Progression to Blast Crisis and Shorter Survival: A Study by the GIMEMA Working Party on Chronic Myeloid Leukemia PDF
Cited by 372
OpenAlex
NephrologyDialysis Transplantation Proteinuria and blood pressure as causal components of progression to end-stage renal failure
Cited by 0
Semantic Scholar
Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial
Cited by 330
OpenAlex
Long-term progression of chronic renal insufficiency in the AIPRI Extension Study. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group.
Cited by 61
Semantic Scholar
Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency
Cited by 1,768
OpenAlex
Low-protein diet and chronic renal failure
Cited by 9
Semantic Scholar
Research Topics
Hemoglobinopathies and Related Disorders
(14)
Iron Metabolism and Disorders
(11)
Blood Pressure and Hypertension Studies
(8)
Chronic Myeloid Leukemia Treatments
(5)
Myeloproliferative Neoplasms: Diagnosis and Treatment
(5)
Affiliations
Novartis (Switzerland)
University of Milan
Luigi Sacco Hospital
Novartis (France)
Novartis (United States)